Injectable: sector benchmark
Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.
Injectable
Summary
Injectable does better than half of its sector on 7 of the 7 ratios compared.
- Working-capital ratiobetter than 86%
- Return on assetsbetter than 83%
- Current ratiobetter than 78%
No ratio below the sector median.
Solvency and debt
Solvency is above 77% of 20,848 sector peers: in the most favourable quarter.
Debt to equity is below 70% of 20,598 sector peers: more favourable than the median.
Interest coverage is above 55% of 19,079 sector peers: more favourable than the median.
Liquidity
The current ratio is above 78% of 20,712 sector peers: in the most favourable quarter.
The working-capital ratio is above 86% of 20,836 sector peers: in the most favourable quarter.
Profitability
Return on equity is above 71% of 18,699 sector peers: more favourable than the median.
Return on assets is above 83% of 20,921 sector peers: in the most favourable quarter.
Not computable
Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.
Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.